Tests:Cholesterol-HDL Ratio, Plasma: Difference between revisions
- Department
- Biochemistry
Tests:Cholesterol-HDL Ratio, Plasma
No edit summary |
No edit summary |
||
| Line 25: | Line 25: | ||
|- | |- | ||
|Specimen Type | |Specimen Type | ||
|6 mL <span style="background:#e30022"> red </span>, or 4 mL Li-Hep </span> or Li-Hep <span style="background:#3cb371"> green-top </span> | |6 mL <span style="background:#e30022"> red top</span>, or 4 mL Li-Hep </span> or Li-Hep <span style="background:#3cb371"> green-top </span> | ||
|- | |- | ||
|Specimen Transportation | |Specimen Transportation | ||
Revision as of 16:17, 20 January 2025
Overview | |
|---|---|
| Department | Biochemistry |
| Test Code | LIPS |
| Synonyms | Lipid profile |
| Turnaround Time | 2 hours |
| Stability – Add test | 24 hours |
Specimen Requirements | |
| Specimen Type | 6 mL red top, or 4 mL Li-Hep or Li-Hep green-top |
| Specimen Transportation | |
| Preferred | |
| Acceptable | |
| Pediatric Requirements | Heparin microtainer tube 600 µL |
Aliquot Requirements | |
| Sample Type | |
| Minimum Volume | |
| Aliquot Transportation | |
Clinical Information | |
| Reference Intervals | |
| Test Method | Abbott Enzymatic reagent on the Abbott Architect ci8200 analyser |
| Advanced Notice | |
| Patient Preparation | |
Comments | |
| Help for Lipid Studies Interpretation
Reported Comments: 1. All reports get this comment (see below for additional information on optimal levels): "Optimal levels are suggested by the New Zealand Guidelines Group though an individualised multi-factorial approach is preferred." 2. All reports get this comment, unless superseded by any one or more of the other comments below: "Cardiovascular risk should be addressed by lifestyle and pharmacological interventions in subjects with 5-year CV risk greater than 15%." 3. Total cholesterol >8 mmol/L or Total cholesterol/HDL ratio >8: | |